pharma · Severe Alpha-1 Antitrypsin Deficiency (AATD)
Grifols
Instituto Grifols S.A.
Grifols patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
ES HQ
1909 Founded
14,121 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- ES
- Founded
- 1909
- Employees
- 14,121
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Grifols patents
0 pharmaceutical patents indexed for Grifols. 0 expire within 24 months.
Grifols has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Grifols have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Grifols patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.